SPOTLIGHT -
2005 rate card
FDA accepts BLA for Sandoz proposed denosumab biosimilar
The US Food and Drug Administration has accepted the Biologics License Application (BLA) for a proposed biosimilar of denosumab (Prolia and Xgeva; Amgen) for treatment of various conditions.
Read More
Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2
This is part 2 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.
Listen
Cleveland Clinic reexamines syphilis testing strategies after rise in cases
After observing an increase in the rate of syphilis cases, the Cleveland Clinic Ob/Gyn & Women’s Health Institute has partnered with the Center for Pediatric Infectious Diseases to evaluate the effectiveness of current testing strategies.
Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1
This is part 1 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.
Elevated lifetime estrogen exposure could increase stroke risk in women
An analysis of data from the China Kadoorie Biobank study suggests cumulative exposure to estrogen was associated with stroke risk in postmenopausal women.
Upcoming event! Free webinar with continuing education credits
